InsidersTradesSigma
Follow the 비보존 제약 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 비보존 제약 has logged 8 reports. Market capitalisation: €144.6bn. The latest transaction was filed on 1 July 2026 (Other). Among the most active insiders: 비보존홀딩스. All data is accessible without an account.
8
Insider Decl.
n/a
Thresholds
€967,544
6 ops.
Buy Volume
n/a
n/a
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,564 of 29,062 companies
24.1
score / 100
Value18
Quality30
FCF yld-4.6%
Earn yld-16%
EV/EBITDA·
ROE·
Gross mgn41%
Net mgn-55%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 July 2026
Declarations8 total
8 of 8 declarations
关于 비보존 제약
Vivozon Pharmaceutical 是一家在 XKRX 市场上市的健康和制药公司。它专注于开发创新的治疗方法和治疗解决方案。